Insights into COVID-19’s aftermath: 2-year study examines lasting health effects

Researchers comprehensively assessed the risks and burdens of post-acute sequelae of coronavirus disease 2019.

Eli Lilly continues radiopharma push with $140m Radionetics partnership – Pharmaceutical Technology

Several big pharmas have made plays into the fast-growing radiopharma space. Image credit: Shutterstock/ Ezume Images. Eli Lilly has partnered with Radionetics Oncology in a

July 2, 2024

Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval – Pharmaceutical Technology

Imvanex generated revenue of $730m for Bavarian Nordic in 2023. Image credit: Shutterstock/ davide bonaldo. The European Medicines Agency’s Committee for Medicinal Products for Human

July 26, 2024

Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 – Biotech Investments

Relief Therapeutics Holding SA / Key word(s): Study Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 02.09.2024 / 07:00 CET/CEST Relief Therapeutics

September 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.